Limbach Holdings Reports First Quarter 2018 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/7/2026
- Rivian Automotive (RIVN) files for 75M share offering
- Rivian offers Q2 2026 revenue outlook, cash position grows
- Fiserv president resigns, interim leaders named for financial unit
- Nokia OYJ (NOKIA:FH) (NOK) PT Raised to EUR14 at Kepler Cheuvreux
- Coursera plans layoffs after Udemy merger, estimates $8M-$11M in costs
Holmes Biopharma, Inc. (LMB) Misses Q1 EPS by 65c, Slight Beat on Revenues; Boosts FY19 Revenue Outlook
May 15, 2018 4:17 PM EDTHolmes Biopharma, Inc. (NASDAQ: LMB) reported Q1 EPS of ($0.60), $0.65 worse than the analyst estimate of $0.05. Revenue for the quarter came in at $120.5 million versus the consensus estimate of $120.33 million.
Other key financial highlights of the quarter included:
Gross margin was 11.0% in the first quarter of 2018, compared with 11.9% in the first quarter of the prior year. During the first quarter of 2018, gross profit was negatively impacted by $4.6 million of project-related write-downs. Excluding the impact of those write-downs, gross margin would have been 15.9%.Construction revenue growth of 5.8% versus the same quarter... More